{"DataElement":{"publicId":"4260918","version":"1","preferredName":"Central Nervous System Disease or Disorder Response CNS Disease or Disorder Response Status","preferredDefinition":"The part of the nervous system that consists of the brain, spinal cord, and meninges._Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function._Any act or phenomena, or behavior, constituting a reply or reaction of a living organism or its part to some foregoing stimulus or agent._A condition or state at a particular time.","longName":"4253105v1.0:4253136v1.0","context":"PBTC","contextVersion":"1","DataElementConcept":{"publicId":"4253105","version":"1","preferredName":"Central Nervous System Disease or Disorder Response","preferredDefinition":"The part of the nervous system that consists of the brain, spinal cord, and meninges._Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function._Any act or phenomena, or behavior, constituting a reply or reaction of a living organism or its part to some foregoing stimulus or agent.","longName":"2962103v1.0:2177336v1.0","context":"PBTC","contextVersion":"1","ObjectClass":{"publicId":"2962103","version":"1","preferredName":"Central Nervous System Disease or Disorder","preferredDefinition":"The main information-processing organs of the nervous system, consisting of the brain, spinal cord, and meninges.:Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function.","longName":"C12438:C2991","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Central Nervous System","conceptCode":"C12438","definition":"The part of the nervous system that consists of the brain, spinal cord, and meninges.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Disease or Disorder","conceptCode":"C2991","definition":"Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"78BB83E7-2969-8122-E040-BB89AD4367EA","latestVersionIndicator":"Yes","beginDate":"2009-11-19","endDate":null,"createdBy":"ZHANGW","dateCreated":"2009-11-19","modifiedBy":"ONEDATA","dateModified":"2009-11-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2193203","version":"1","preferredName":"Response","preferredDefinition":"Response is any act or phenomena, or behavior, constituting a reply or reaction of a living organism or its part to some foregoing stimulus or agent.","longName":"C25755","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Response","conceptCode":"C25755","definition":"Any act or phenomena, or behavior, constituting a reply or reaction of a living organism or its part to some foregoing stimulus or agent.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"EACFDBFA-EFCE-25E6-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-12-09","endDate":null,"createdBy":"MAESKEB","dateCreated":"2004-12-09","modifiedBy":"DATA_LOADER","dateModified":"2005-10-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008550","version":"1","preferredName":"Disease Response","preferredDefinition":"the response criteria (includes RECIST and others) and associated documentation of disease.","longName":"DZ_RESP","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22C0651-216B-5273-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F5872458-78BB-CF5D-E040-BB89AD4336D6","latestVersionIndicator":"Yes","beginDate":"2014-03-26","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2014-03-26","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":"PBTC_ghd_03/26/14","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"4253136","version":"1","preferredName":"CNS Disease or Disorder Response Status","preferredDefinition":"A condition or state at a particular time.","longName":"4253136v1.0","context":"PBTC","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"10","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"PD (NOS)","valueDescription":"PD, not otherwise specified","ValueMeaning":{"publicId":"4261093","version":"1","preferredName":"PD, not otherwise specified","longName":"4261093","preferredDefinition":"A <25% increase in the bi-dimensional measurement, taking as a reference the smallest disease measurement recorded since the start of protocol therapy, OR the appearance of a new lesion","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F600AD3A-ACA6-073E-E040-BB89AD431C87","latestVersionIndicator":"Yes","beginDate":"2014-04-01","endDate":null,"createdBy":"RICHARDS","dateCreated":"2014-04-01","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F600AD3A-ACBF-073E-E040-BB89AD431C87","beginDate":"2014-04-01","endDate":null,"createdBy":"RICHARDS","dateCreated":"2014-04-01","modifiedBy":"ONEDATA","dateModified":"2014-04-01","deletedIndicator":"No"},{"value":"SD","valueDescription":"Stable Disease","ValueMeaning":{"publicId":"4261094","version":"1","preferredName":"Stable Disease","longName":"4261094","preferredDefinition":"Neurologic exam is at least stable and maintenance corticosteroid dose not increased, and MR/CT imaging meets neither the criteria for PR nor the criteria for PD.","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F600AD3A-ACC9-073E-E040-BB89AD431C87","latestVersionIndicator":"Yes","beginDate":"2014-04-01","endDate":null,"createdBy":"RICHARDS","dateCreated":"2014-04-01","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F600AD3A-ACE1-073E-E040-BB89AD431C87","beginDate":"2014-04-01","endDate":null,"createdBy":"RICHARDS","dateCreated":"2014-04-01","modifiedBy":"ONEDATA","dateModified":"2014-04-01","deletedIndicator":"No"},{"value":"PR","valueDescription":"Partial Response","ValueMeaning":{"publicId":"4261095","version":"1","preferredName":"Partial Response","longName":"4261095","preferredDefinition":">=50% reduction in tumor size by bi-dimensional measurement as compared with the baseline measurements, on a stable of decreasing dose of corticosteroids, accompanied by a stable or improving neurologic exam and maintained for at least 8 weeks","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F600AD3A-ACEB-073E-E040-BB89AD431C87","latestVersionIndicator":"Yes","beginDate":"2014-04-01","endDate":null,"createdBy":"RICHARDS","dateCreated":"2014-04-01","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F600AD3A-AD03-073E-E040-BB89AD431C87","beginDate":"2014-04-01","endDate":null,"createdBy":"RICHARDS","dateCreated":"2014-04-01","modifiedBy":"ONEDATA","dateModified":"2014-04-01","deletedIndicator":"No"},{"value":"CR","valueDescription":"Complete Response","ValueMeaning":{"publicId":"4253137","version":"1","preferredName":"Complete Response","longName":"4253137","preferredDefinition":"Disappearance on MR/CT of all tumor and mass effect, on a stable or decreasing dose of corticosteroids (or receiving on renal replacement doses), accompanied by a stable of improving neurological examination, and maintained for at least 8 weeks.","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F5872458-78E2-CF5D-E040-BB89AD4336D6","latestVersionIndicator":"Yes","beginDate":"2014-03-26","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2014-03-26","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F5872458-78FA-CF5D-E040-BB89AD4336D6","beginDate":"2014-03-26","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2014-03-26","modifiedBy":"ONEDATA","dateModified":"2014-03-26","deletedIndicator":"No"},{"value":"CP","valueDescription":"Clinical Progression Non-Radiological Progression","ValueMeaning":{"publicId":"4258731","version":"1","preferredName":"Clinical Progression Non-Radiological Progression","longName":"4258731","preferredDefinition":"Progressive neurologic abnormalities or worsening neurologic status not explained by causes unrelated to tumor progression  OR increasing doses of corticosteroids required to maintain stable neurological status or imaging.","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F5E96F89-6B81-81F7-E040-BB89AD4364E9","latestVersionIndicator":"Yes","beginDate":"2014-03-31","endDate":null,"createdBy":"SWEW","dateCreated":"2014-03-31","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F5E96F89-6B9A-81F7-E040-BB89AD4364E9","beginDate":"2014-03-31","endDate":null,"createdBy":"SWEW","dateCreated":"2014-03-31","modifiedBy":"ONEDATA","dateModified":"2014-03-31","deletedIndicator":"No"},{"value":"NED","valueDescription":"No Evidence of Disease","ValueMeaning":{"publicId":"4258732","version":"1","preferredName":"No Evidence of Disease","longName":"4258732","preferredDefinition":"Disappearance of MR/CT of all tumor and mass effect but too early to code as CR","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F5E96F89-6BA4-81F7-E040-BB89AD4364E9","latestVersionIndicator":"Yes","beginDate":"2014-03-31","endDate":null,"createdBy":"SWEW","dateCreated":"2014-03-31","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F5E96F89-6BBC-81F7-E040-BB89AD4364E9","beginDate":"2014-03-31","endDate":null,"createdBy":"SWEW","dateCreated":"2014-03-31","modifiedBy":"ONEDATA","dateModified":"2014-03-31","deletedIndicator":"No"},{"value":"NER","valueDescription":"Not Evaluable for Response","ValueMeaning":{"publicId":"4258733","version":"1","preferredName":"Not Evaluable for Response","longName":"4258733","preferredDefinition":"Disease assessment is not suitable to determine response","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F5E96F89-6BC6-81F7-E040-BB89AD4364E9","latestVersionIndicator":"Yes","beginDate":"2014-03-31","endDate":null,"createdBy":"SWEW","dateCreated":"2014-03-31","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F5E96F89-6BDF-81F7-E040-BB89AD4364E9","beginDate":"2014-03-31","endDate":null,"createdBy":"SWEW","dateCreated":"2014-03-31","modifiedBy":"ONEDATA","dateModified":"2014-03-31","deletedIndicator":"No"},{"value":"PD &#8805;50%","valueDescription":"Progressive Disease, >=50%","ValueMeaning":{"publicId":"4258734","version":"1","preferredName":"Progressive Disease, >=50%","longName":"4258734","preferredDefinition":"A > 50% increase in the bi-dimensional measurement, taking as a reference the smallest disease measurement recorded since the start of protocol therapy, OR the appearance of a new lesion.","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F5E96F89-6BE9-81F7-E040-BB89AD4364E9","latestVersionIndicator":"Yes","beginDate":"2014-03-31","endDate":null,"createdBy":"SWEW","dateCreated":"2014-03-31","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F5E96F89-6C02-81F7-E040-BB89AD4364E9","beginDate":"2014-03-31","endDate":null,"createdBy":"SWEW","dateCreated":"2014-03-31","modifiedBy":"ONEDATA","dateModified":"2014-03-31","deletedIndicator":"No"},{"value":"PD 25-49%","valueDescription":"Progressive Disease, 25-49%","ValueMeaning":{"publicId":"4258735","version":"1","preferredName":"Progressive Disease, 25-49%","longName":"4258735","preferredDefinition":"A 25%-49%  increase in the bi-dimensional measurement, taking as a reference the smallest disease measurement recorded since the start of protocol therapy, OR the appearance of a new lesion.","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F5E96F89-6C0C-81F7-E040-BB89AD4364E9","latestVersionIndicator":"Yes","beginDate":"2014-03-31","endDate":null,"createdBy":"SWEW","dateCreated":"2014-03-31","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F5E96F89-6C25-81F7-E040-BB89AD4364E9","beginDate":"2014-03-31","endDate":null,"createdBy":"SWEW","dateCreated":"2014-03-31","modifiedBy":"ONEDATA","dateModified":"2014-03-31","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008550","version":"1","preferredName":"Disease Response","preferredDefinition":"the response criteria (includes RECIST and others) and associated documentation of disease.","longName":"DZ_RESP","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22C0651-216B-5273-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2404650","version":"1","preferredName":"Status","preferredDefinition":"A condition or state at a particular time.","longName":"C25688","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Status","conceptCode":"C25688","definition":"A condition or state at a particular time.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"005AD6E5-057F-6A35-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-09-09","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-09-09","modifiedBy":"ONEDATA","dateModified":"2005-09-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F5872458-78CD-CF5D-E040-BB89AD4336D6","latestVersionIndicator":"Yes","beginDate":"2014-03-26","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2014-03-26","modifiedBy":"SBREXT","dateModified":"2016-09-15","changeDescription":"PBTC","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[{"name":"CNS_DIS_RES_STAT","type":"Context Short Name","context":"PBTC"}],"ReferenceDocuments":[{"name":"Evaluate Response","type":"Preferred Question Text","description":"Evaluate Response","url":null,"context":"PBTC"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F600AD3A-AB7A-073E-E040-BB89AD431C87","latestVersionIndicator":"Yes","beginDate":"2014-04-01","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2014-04-01","modifiedBy":"SWEW","dateModified":"2015-03-18","changeDescription":"PBTC_STD_ghd_04/01/14","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}